By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company Dezhan Healthcare Company Limited

Dezhan Healthcare Company Limited (000813.SZ)

SHZ Currency in CNY
¥3.41
-¥0.01
-0.29%
Last Update: 11 Jul 2025, 07:04
¥7.38B
Market Cap
-501.47
P/E Ratio (TTM)
Forward Dividend Yield
¥2.20 - ¥5.08
52 Week Range

000813.SZ Stock Price Chart

Explore Dezhan Healthcare Company Limited interactive price chart. Choose custom timeframes to analyze 000813.SZ price movements and trends.

There is nothing to show.

000813.SZ Company Profile

Discover essential business fundamentals and corporate details for Dezhan Healthcare Company Limited (000813.SZ) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

19 May 1998

Employees

1.00K

CEO

Wei Liu

Description

Dezhan Healthcare Company Limited researches and develops, manufactures, and sells cardiovascular and cerebrovascular drugs in China. It also offers anti-cancer drugs, health care products, functional beverages, and ecological water. The company was founded in 1998 and is based in Urumqi, China.

000813.SZ Financial Timeline

Browse a chronological timeline of Dezhan Healthcare Company Limited corporate events including earnings releases, dividend announcements, and stock splits.

Earnings released on 8 May 2025

EPS came in at -¥0.01, while revenue for the quarter reached ¥112.01M.

Earnings released on 31 Mar 2025

EPS came in at -¥0.01, while revenue for the quarter reached ¥89.28M.

Earnings released on 29 Sept 2024

EPS came in at -¥0.00, while revenue for the quarter reached ¥106.16M.

Earnings released on 30 Jun 2024

EPS came in at ¥0.01, while revenue for the quarter reached ¥144.24M.

Earnings released on 8 May 2024

EPS came in at ¥0.01, while revenue for the quarter reached ¥162.94M.

Earnings released on 30 Mar 2024

EPS came in at -¥0.01, while revenue for the quarter reached ¥98.17M.

Earnings released on 30 Sept 2023

EPS came in at ¥0.03, while revenue for the quarter reached ¥114.33M.

Earnings released on 30 Jun 2023

EPS came in at -¥0.00, while revenue for the quarter reached ¥85.65M.

Earnings released on 31 Mar 2023

EPS came in at ¥0.00, while revenue for the quarter reached ¥135.16M.

Earnings released on 1 Jan 2023

EPS came in at -¥0.05, while revenue for the quarter reached ¥154.23M.

Earnings released on 30 Sept 2022

EPS came in at ¥0.00, while revenue for the quarter reached ¥112.62M.

Earnings released on 30 Jun 2022

EPS came in at ¥0.01, while revenue for the quarter reached ¥111.18M.

Earnings released on 29 Apr 2022

EPS came in at -¥0.09, while revenue for the quarter reached ¥221.61M.

Earnings released on 29 Apr 2022

EPS came in at ¥0.01, while revenue for the quarter reached ¥192.82M, missing expectations by -93.77%.

Earnings released on 1 Nov 2021

EPS came in at ¥0.02, while revenue for the quarter reached ¥180.23M.

Earnings released on 30 Sept 2021

EPS came in at ¥0.01, while revenue for the quarter reached ¥121.05M.

Dividend declared on 1 Jun 2021

A dividend of ¥0.21 per share was announced, adjusted to ¥0.21. The dividend was paid on 1 Jun 2021.

Earnings released on 31 Mar 2021

EPS came in at ¥0.03, while revenue for the quarter reached ¥211.59M.

Earnings released on 31 Dec 2020

EPS came in at ¥0.02, while revenue for the quarter reached ¥124.11M.

Earnings released on 30 Sept 2020

EPS came in at ¥0.03, while revenue for the quarter reached ¥124.16M.

000813.SZ Stock Performance

Access detailed 000813.SZ performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

There is nothing to show.
000813.SZ
Company Name
Exchange
Market Currency
Report Currency
Price
Price Change
Percentage Change
50-Day Average Price
200-Day Average Price
Trading Volume
Market Capitalization
000813.SZ
2025
2024
2023
2022
2021
Revenue
Gross Profit
Earnings Before Interest and Taxes (EBIT)
Net Income
Total Current Assets
Total Assets
Total Liabilities
Net Debt
Total Equity
Cash Flow from Operating
Cash Flow from Investing
Cash Flow from Financing
Free Cash Flow

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More